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Introduction
Juvenile systemic lupus erythematosus (JSLE) is a chronic,
autoimmune and multisystem disease. Adult patients with
SLE have an elevated risk of premature atherosclerosis
and myocardial infarction. Dyslipidemia is a risk factor for
the development of future chronic diseases and is asso-
ciated with disease activity, corticosteroids use (CTC),
renal impairment, among other factors.
Other biochemical markers have been proposed for
identification of cardiovascular risk, among them the pro-
tein components of lipoproteins (apolipoproteins - Apo)
and enzyme related to cardiovascular risk (paraoxonase -
PON).
Objectives
To evaluate the biochemical markers related to cardio-
vascular risk in adolescents with JSLE.
Methods
Cross-sectional and controlled study including 33 female
adolescents with JSLE and 33 healthy controls. We evalu-
ated: lipid profile, Apo A1, Apo B, PON activity and body
mass index (BMI). For classification of lipid profile we
considered cutoff points proposed by the American Acad-
emy of Pediatrics. Statistical analysis: Mann-Whitney test.
Results
The median age and SLEDAI of the patients were 16 years
and 2 (0, 12), respectively. We observed SLEDAI > 4 in
33%, nephrotic syndrome in 12%, CTC use in 75.8% [med-
ian dose 0.18 (0.05, 0.6) mg/kg/day] and hydroxychloro-
quine use in 93.9% of the patients. Overweight/obesity was
observed in 36.4 %; dyslipidemia in 39.4 and 21.2 % of
patients and controls, respectively. Hypertriglyceridemia
and low HDL -C were the most frequent alterations. Apo
A1 concentrations were significantly higher in controls
(p = 0.01). There was no statistical difference in the lipid
profile, in the concentrations of Apo B (p = 0.85) and in
PON activity (p = 0.062). There were statistical differences
in the relations Apo B/Apo A (p = 0.000) and LDL/Apo B
(p = 0.000).
Conclusion
Low concentrations of Apo A1 in patients suggest a dys-
functional HDL cholesterol, possibly due to inflammation.
The results indicate increased cardiovascular risk in ado-
lescents with JSLE compared with healthy controls.
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